Top Markets
#1 The Black Bull The Black Bull +22.59%
#2 EXOD EXOD +22.08%
#3 SSV Network SSV Network +21.25%
#4 Useless Coin Useless Coin +20.34%
#5 Geodnet Geodnet +20.31%
#6 Ore Ore +20.14%
#7 XPIN Network XPIN Network +19.03%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.93%
#9 Wrapped XPL Wrapped XPL +18.69%
#10 Plasma Plasma +18.68%
Coin of the day
The Black Bull The Black Bull
Settings
Language
ENGLISH
Currency
USD
Theme
Advagene Biopharma Co., Ltd. Advagene Biopharma Co., Ltd.

Advagene Biopharma Co., Ltd.

6709
Rank in Stocks #24966
Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to... Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to pioneering advancements in vaccine science and associated medical solutions. Its current development portfolio comprises a nasal spray vaccine for influenza, various allergy-specific vaccines, and an immunotherapy targeting COVID-19.
Share Price
$0.79974555
Market Cap
$54.69M
Change (1 day)
-4.73%
Change (1 year)
11.75%
Country
TW
Trade Advagene Biopharma Co., Ltd. (6709)

Category

Healthcare
Earnings for Advagene Biopharma Co., Ltd. (6709)
Earnings in 2026 TTM: 0
According to Advagene Biopharma Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Advagene Biopharma Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US